» Articles » PMID: 35324477

Antibody-dependent Cellular Cytotoxicity Responses and Susceptibility Influence HIV-1 Mother-to-child Transmission

Overview
Journal JCI Insight
Date 2022 Mar 24
PMID 35324477
Authors
Affiliations
Soon will be listed here.
Abstract

HIV-1 vaccine efforts are primarily directed toward eliciting neutralizing antibodies (nAbs). However, vaccine trials and mother-to-child natural history cohort investigations indicate that antibody-dependent cellular cytotoxicity (ADCC), not nAbs, correlate with prevention. The ADCC characteristics associated with lack of HIV-1 acquisition remain unclear. Here, we examine ADCC and nAb properties in pretransmission plasma from HIV-1-exposed infants and from the corresponding transmitting and nontransmitting mothers' breast milk and plasma. Breadth and potency (BP) were assessed against a panel of heterologous, nonmaternal variants. ADCC and neutralization sensitivity were estimated for the strains in the infected mothers. Infants who eventually acquired HIV-1 and those who remained uninfected had similar pretransmission ADCCBP. Viruses circulating in the transmitting and nontransmitting mothers had similar ADCC susceptibility. Infants with higher pretransmission ADCCBP and exposure to more ADCC-susceptible strains were less likely to acquire HIV-1. In contrast, higher preexisting infant neutralization BP and greater maternal virus neutralization sensitivity did not associate with transmission. Infants had higher ADCCBP closer to birth and in the presence of high plasma IgG relative to IgA levels. Mothers with potent humoral responses against their autologous viruses harbored more ADCC-sensitive strains. ADCC sensitivity of the exposure variants and preexisting ADCCBP influenced mother-to-child HIV-1 transmission during breastfeeding. Vaccination strategies that enhance ADCC are likely insufficient to prevent HIV-1 transmission because some strains may have low ADCC susceptibility.

Citing Articles

In utero human cytomegalovirus infection expands NK-like FcγRIII+CD8+ T cells that mediate Fc antibody functions.

Semmes E, Nettere D, Nelson A, Hurst J, Cain D, Burt T J Clin Invest. 2024; 135(1).

PMID: 39531313 PMC: 11684805. DOI: 10.1172/JCI181342.


Sequence Matters: Primary COVID-19 Vaccination after Infection Elicits Similar Anti-spike Antibody Levels, but Stronger Antibody Dependent Cell-mediated Cytotoxicity than Breakthrough Infection.

Holder K, Ings D, Fifield K, Barnes D, Barnable K, Harnum D J Immunol. 2024; 213(8):1105-1114.

PMID: 39248629 PMC: 11457723. DOI: 10.4049/jimmunol.2400250.


Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection.

Mader K, Dustin L Antibodies (Basel). 2024; 13(2).

PMID: 38651408 PMC: 11036282. DOI: 10.3390/antib13020028.


Infant feeding: emerging concepts to prevent HIV transmission.

Bamford A, Foster C, Lyall H Curr Opin Infect Dis. 2023; 37(1):8-16.

PMID: 37889586 PMC: 10734781. DOI: 10.1097/QCO.0000000000000986.


B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa.

Cotugno N, Pallikkuth S, Sanna M, Dinh V, de Armas L, Rinaldi S EBioMedicine. 2023; 93:104666.

PMID: 37406590 PMC: 10363429. DOI: 10.1016/j.ebiom.2023.104666.


References
1.
Chung A, Isitman G, Navis M, Kramski M, Center R, Kent S . Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure. Proc Natl Acad Sci U S A. 2011; 108(18):7505-10. PMC: 3088575. DOI: 10.1073/pnas.1016048108. View

2.
Thomas A, Ghulam-Smith M, Olson A, Coote C, Gonzales O, Sagar M . A new cell line for assessing HIV-1 antibody dependent cellular cytotoxicity against a broad range of variants. J Immunol Methods. 2020; 480:112766. PMC: 7188583. DOI: 10.1016/j.jim.2020.112766. View

3.
Mor G, Cardenas I . The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010; 63(6):425-33. PMC: 3025805. DOI: 10.1111/j.1600-0897.2010.00836.x. View

4.
Pollara J, McGuire E, Fouda G, Rountree W, Eudailey J, Overman R . Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1. J Virol. 2015; 89(19):9952-61. PMC: 4577885. DOI: 10.1128/JVI.01560-15. View

5.
Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R . Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009; 361(23):2209-20. DOI: 10.1056/NEJMoa0908492. View